Cisplatin is a weak inducer of ARE in the MCF-7 human breast cancer cell line (without KEAP1 mutation [38]) and induces a 1.3-fold change in ARE expression levels after 24 h of exposure [15], consistently with our observations in wild-type KEAP1 NSCLC cells. The gene discussed is KEAP1; the disease is breast cancer.